NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

洛沙坦的全球市場 - 各採購,各形態,各強度,各流通管道,各用途,各終端用戶,各地區,預測,機會:2026年

Global Losartan Market, By Source, By Form, By Strength, By Distribution Channel, By Application, By End-User, By Region, Forecast & Opportunities, 2026

出版商 TechSci Research 商品編碼 995910
出版日期 內容資訊 英文 117 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

洛沙坦的全球市場 - 各採購,各形態,各強度,各流通管道,各用途,各終端用戶,各地區,預測,機會:2026年 Global Losartan Market, By Source, By Form, By Strength, By Distribution Channel, By Application, By End-User, By Region, Forecast & Opportunities, 2026
出版日期: 2021年03月01日內容資訊: 英文 117 Pages
簡介

全球洛沙坦市場,2020年達到47億3,000萬美元,在預測期間內預計以7.81%的年複合成長率成長。

全球洛沙坦市場,由於在全球高血壓,中風,糖尿病腎病變的盛行率持續增加而受到促進。洛沙坦是治療高血壓所使用的藥。

本報告提供全球洛沙坦市場相關調查分析,市場規模、佔有率、預測,各市場區隔分析,競爭分析,市場趨勢的變化,新興機會相關的系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球洛沙坦市場的影響

第4章 摘要整理

第5章 客戶的迴響

第6章 全球洛沙坦市場預測

  • 市場規模與預測
    • 各金額、數量
  • 市場佔有率與預測
    • 各採購 (CMO,公司內部)
    • 各形態 (錠劑,粉末)
    • 各強度 (25mg,50mg,100mg,其他)
    • 各流通管道 (離線,線上)
    • 各用途 (高血壓,中風,糖尿病腎病變,其他)
    • 各終端用戶 (成人,兒童)
    • 各企業
    • 各地區
  • 產品市場地圖

第7章 北美的洛沙坦市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各採購
    • 各形態
    • 各強度
    • 各流通管道
    • 各用途
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國的洛沙坦市場預測
    • 加拿大的洛沙坦市場預測
    • 墨西哥的洛沙坦市場預測

第8章 歐洲的洛沙坦市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各採購
    • 各形態
    • 各強度
    • 各流通管道
    • 各用途
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 德國的洛沙坦市場預測
    • 法國的洛沙坦市場預測
    • 英國的洛沙坦市場預測
    • 義大利的洛沙坦市場預測
    • 西班牙的洛沙坦市場預測
    • 俄羅斯的洛沙坦市場預測
    • 波蘭的洛沙坦市場預測

第9章 亞太地區的洛沙坦市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各採購
    • 各形態
    • 各強度
    • 各流通管道
    • 各用途
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 中國的洛沙坦市場預測
    • 日本的洛沙坦市場預測
    • 印度的洛沙坦市場預測
    • 澳洲的洛沙坦市場預測
    • 韓國的洛沙坦市場預測
    • 香港的洛沙坦市場預測
    • 菲律賓的洛沙坦市場預測
    • 馬來西亞的洛沙坦市場預測
    • 印尼的洛沙坦市場預測
    • 越南的洛沙坦市場預測
    • 泰國的洛沙坦市場預測

第10章 南美的洛沙坦市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各採購
    • 各形態
    • 各強度
    • 各流通管道
    • 各用途
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西的洛沙坦市場預測
    • 阿根廷的洛沙坦市場預測
    • 哥倫比亞的洛沙坦市場預測
    • 智利的洛沙坦市場預測

第11章 中東、非洲的洛沙坦市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各採購
    • 各形態
    • 各強度
    • 各流通管道
    • 各用途
    • 各終端用戶
    • 各國
  • 中東、非洲:各國分析
    • 南非的洛沙坦市場預測
    • 沙烏地阿拉伯的洛沙坦市場預測
    • 阿拉伯聯合大公國的洛沙坦市場預測
    • 土耳其的洛沙坦市場預測
    • 奈及利亞的洛沙坦市場預測
    • 肯亞的洛沙坦市場預測
    • 阿爾及利亞的洛沙坦市場預測
    • 衣索比亞的洛沙坦市場預測

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Novartis International AG
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceuticals Industries Ltd.
  • Aurobindo Pharma Ltd.
  • Torrent Pharmaceutical Ltd.
  • Lupin Ltd.
  • Mylan N.V.
  • Ipca Laboratories Limited
  • Macleods Pharmaceuticals Limited
  • Abbott Laboratories
  • Cadila Healthcare Limited

第15章 策略性建議

第16章 關於出版社、免責聲明

目錄
Product Code: 7269

Title:
Global Losartan Market, By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By End-User (Adult, Pediatric), By Region, Forecast & Opportunities, 2026.

Global losartan market was valued at USD4.73 billion in 2020 and is expected to grow at a formidable rate of 7.81% during the forecast period. The global losartan market is driven by the growing prevalence of hypertension, stroke and diabetic nephropathy across the world. Losartan is a medication that is used to treat high blood pressure. Furthermore, losartan is widely used in slowing down long-term kidney damage due to type II diabetes which is further expected to propel the market growth through 2026. The sudden outbreak and spread of the COVID-19 pandemic has resulted in the loss of jobs for many people due to which the level of anxiety and hypertension has increased among the people. This has, in turn, increased the demand for losartan, thereby fueling the market growth during the forecast period. Many major biotechnology and pharmaceutical companies are working on manufacturing in-house losartan tablets which are expected to create lucrative opportunities for the market growth over the next few years.

The global losartan market is segmented based on source, form, strength, distribution channel, application, end-user, company and region. Based on source, the market can be split into contract manufacturing organizations and in-house. Among these, the in-house segment is expected to witness the fastest growth due to increased preference for in-house manufacturing by key market players as the company can have full control over the quality and the quantity of the products. Based on form, the market can be fragmented into tablets and powder. Here, the tablet segment is dominating the market with a market share of nearly 87% and is expected to maintain its position in the forecast years as well. Based on distribution channel, the market can be segmented into online and offline. The offline channel is expected to dominate the market due to surging consumer preference for purchasing medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years.

Regionally, the global losartan market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate in the overall losartan market owing to the well-established healthcare infrastructure and presence of major pharmaceutical and biotechnology giants in the region. However, Asia-Pacific is expected to witness robust growth in the market owing to the presence of a large pool of patients suffering from various life-threatening conditions in economies such as China and India.

Major players operating in the global losartan market include Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis International AG, Dr. Reddy's Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., Mylan N.V., Ipca Laboratories Limited, Macleods Pharmaceuticals Limited, Abbott Laboratories, Cadila Healthcare Limited, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the global losartan market from 2016 to 2020.
  • To estimate and forecast the market size of the global losartan market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the global losartan market based on source, form, strength, distribution channel, application, end-user, company and regional distribution.
  • To identify dominant region or segment in the global losartan market.
  • To identify drivers and challenges for global losartan market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global losartan market.
  • To identify and analyze the profile of leading players operating in global losartan market.
  • To identify key sustainable strategies adopted by market players in global losartan market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global Losartan market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Losartan manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to losartan kit
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global losartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Losartan Market, By Source:

Contract Manufacturing Organizations

In-House

  • Global Losartan Market, By Form:

Tablet

Powder

  • Global Losartan Market, By Strength:

25 mg

50 mg

100 mg

Others

  • Global Losartan Market, By Distribution Channel:

Offline

Online

  • Global Losartan Market, By Application:

Hypertension

Stroke

Diabetic nephropathy

Others

  • Global Losartan Market, By End-User:

Adult

Pediatric

  • Global Losartan Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Poland

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Hong Kong
  • Philippines
  • Malaysia
  • Indonesia
  • Vietnam
  • Thailand

South America

  • Brazil
  • Argentina
  • Colombia
  • Chile

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Nigeria
  • Kenya
  • Algeria
  • Ethiopia

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in the global losartan market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information:

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Losartan Market

4. Executive Summary

5. Voice of Customer

6. Global Losartan Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source (Contract Manufacturing Organizations, In-House)
    • 6.2.2. By Form (Tablet, Powder)
    • 6.2.3. By Strength (25 mg, 50 mg, 100 mg, Others)
    • 6.2.4. By Distribution Channel (Offline, Online)
    • 6.2.5. By Application (Hypertension, Stroke, Diabetic nephropathy, Others)
    • 6.2.6. By End-User (Adult, Pediatric)
    • 6.2.7. By Company (2020)
    • 6.2.8. By Region
  • 6.3. Product Market Map

7. North America Losartan Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Form
    • 7.2.3. By Strength
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Application
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Losartan Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Source
        • 7.3.1.2.2. By Form
        • 7.3.1.2.3. By Strength
        • 7.3.1.2.4. By Distribution Channel
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By End-User
    • 7.3.2. Canada Losartan Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Source
        • 7.3.2.2.2. By Form
        • 7.3.2.2.3. By Strength
        • 7.3.2.2.4. By Distribution Channel
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By End-User
    • 7.3.3. Mexico Losartan Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Source
        • 7.3.3.2.2. By Form
        • 7.3.3.2.3. By Strength
        • 7.3.3.2.4. By Distribution Channel
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By End-User

8. Europe Losartan Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Form
    • 8.2.3. By Strength
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Application
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Losartan Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Source
        • 8.3.1.2.2. By Form
        • 8.3.1.2.3. By Strength
        • 8.3.1.2.4. By Distribution Channel
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By End-User
    • 8.3.2. France Losartan Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Source
        • 8.3.2.2.2. By Form
        • 8.3.2.2.3. By Strength
        • 8.3.2.2.4. By Distribution Channel
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By End-User
    • 8.3.3. United Kingdom Losartan Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Source
        • 8.3.3.2.2. By Form
        • 8.3.3.2.3. By Strength
        • 8.3.3.2.4. By Distribution Channel
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By End-User
    • 8.3.4. Italy Losartan Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Source
        • 8.3.4.2.2. By Form
        • 8.3.4.2.3. By Strength
        • 8.3.4.2.4. By Distribution Channel
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By End-User
    • 8.3.5. Spain Losartan Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Source
        • 8.3.5.2.2. By Form
        • 8.3.5.2.3. By Strength
        • 8.3.5.2.4. By Distribution Channel
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By End-User
    • 8.3.6. Russia Losartan Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Source
        • 8.3.6.2.2. By Form
        • 8.3.6.2.3. By Strength
        • 8.3.6.2.4. By Distribution Channel
        • 8.3.6.2.5. By Application
        • 8.3.6.2.6. By End-User
    • 8.3.7. Poland Losartan Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Source
        • 8.3.7.2.2. By Form
        • 8.3.7.2.3. By Strength
        • 8.3.7.2.4. By Distribution Channel
        • 8.3.7.2.5. By Application
        • 8.3.7.2.6. By End-User

9. Asia-Pacific Losartan Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Form
    • 9.2.3. By Strength
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Application
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Losartan Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Source
        • 9.3.1.2.2. By Form
        • 9.3.1.2.3. By Strength
        • 9.3.1.2.4. By Distribution Channel
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By End-User
    • 9.3.2. Japan Losartan Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Source
        • 9.3.2.2.2. By Form
        • 9.3.2.2.3. By Strength
        • 9.3.2.2.4. By Distribution Channel
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By End-User
    • 9.3.3. India Losartan Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Source
        • 9.3.3.2.2. By Form
        • 9.3.3.2.3. By Strength
        • 9.3.3.2.4. By Distribution Channel
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By End-User
    • 9.3.4. Australia Losartan Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Source
        • 9.3.4.2.2. By Form
        • 9.3.4.2.3. By Strength
        • 9.3.4.2.4. By Distribution Channel
        • 9.3.4.2.5. By Application
        • 9.3.4.2.6. By End-User
    • 9.3.5. South Korea Losartan Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Source
        • 9.3.5.2.2. By Form
        • 9.3.5.2.3. By Strength
        • 9.3.5.2.4. By Distribution Channel
        • 9.3.5.2.5. By Application
        • 9.3.5.2.6. By End-User
    • 9.3.6. Hong Kong Losartan Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Source
        • 9.3.6.2.2. By Form
        • 9.3.6.2.3. By Strength
        • 9.3.6.2.4. By Distribution Channel
        • 9.3.6.2.5. By Application
        • 9.3.6.2.6. By End-User
    • 9.3.7. Philippines Losartan Market Outlook
      • 9.3.7.1. Market Size & Forecast
        • 9.3.7.1.1. By Value
      • 9.3.7.2. Market Share & Forecast
        • 9.3.7.2.1. By Source
        • 9.3.7.2.2. By Form
        • 9.3.7.2.3. By Strength
        • 9.3.7.2.4. By Distribution Channel
        • 9.3.7.2.5. By Application
        • 9.3.7.2.6. By End-User
    • 9.3.8. Malaysia Losartan Market Outlook
      • 9.3.8.1. Market Size & Forecast
        • 9.3.8.1.1. By Value
      • 9.3.8.2. Market Share & Forecast
        • 9.3.8.2.1. By Source
        • 9.3.8.2.2. By Form
        • 9.3.8.2.3. By Strength
        • 9.3.8.2.4. By Distribution Channel
        • 9.3.8.2.5. By Application
        • 9.3.8.2.6. By End-User
    • 9.3.9. Indonesia Losartan Market Outlook
      • 9.3.9.1. Market Size & Forecast
        • 9.3.9.1.1. By Value
      • 9.3.9.2. Market Share & Forecast
        • 9.3.9.2.1. By Source
        • 9.3.9.2.2. By Form
        • 9.3.9.2.3. By Strength
        • 9.3.9.2.4. By Distribution Channel
        • 9.3.9.2.5. By Application
        • 9.3.9.2.6. By End-User
    • 9.3.10. Vietnam Losartan Market Outlook
      • 9.3.10.1. Market Size & Forecast
        • 9.3.10.1.1. By Value
      • 9.3.10.2. Market Share & Forecast
        • 9.3.10.2.1. By Source
        • 9.3.10.2.2. By Form
        • 9.3.10.2.3. By Strength
        • 9.3.10.2.4. By Distribution Channel
        • 9.3.10.2.5. By Application
        • 9.3.10.2.6. By End-User
    • 9.3.11. Thailand Losartan Market Outlook
      • 9.3.11.1. Market Size & Forecast
        • 9.3.11.1.1. By Value
      • 9.3.11.2. Market Share & Forecast
        • 9.3.11.2.1. By Source
        • 9.3.11.2.2. By Form
        • 9.3.11.2.3. By Strength
        • 9.3.11.2.4. By Distribution Channel
        • 9.3.11.2.5. By Application
        • 9.3.11.2.6. By End-User

10. South America Losartan Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By Form
    • 10.2.3. By Strength
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Application
    • 10.2.6. By End-User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Losartan Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source
        • 10.3.1.2.2. By Form
        • 10.3.1.2.3. By Strength
        • 10.3.1.2.4. By Distribution Channel
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By End-User
    • 10.3.2. Argentina Losartan Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source
        • 10.3.2.2.2. By Form
        • 10.3.2.2.3. By Strength
        • 10.3.2.2.4. By Distribution Channel
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By End-User
    • 10.3.3. Colombia Losartan Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source
        • 10.3.3.2.2. By Form
        • 10.3.3.2.3. By Strength
        • 10.3.3.2.4. By Distribution Channel
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By End-User
    • 10.3.4. Chile Losartan Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Source
        • 10.3.4.2.2. By Form
        • 10.3.4.2.3. By Strength
        • 10.3.4.2.4. By Distribution Channel
        • 10.3.4.2.5. By Application
        • 10.3.4.2.6. By End-User

11. Middle East and Africa Losartan Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Source
    • 11.2.2. By Form
    • 11.2.3. By Strength
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Application
    • 11.2.6. By End-User
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Losartan Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Source
        • 11.3.1.2.2. By Form
        • 11.3.1.2.3. By Strength
        • 11.3.1.2.4. By Distribution Channel
        • 11.3.1.2.5. By Application
        • 11.3.1.2.6. By End-User
    • 11.3.2. Saudi Arabia Losartan Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Source
        • 11.3.2.2.2. By Form
        • 11.3.2.2.3. By Strength
        • 11.3.2.2.4. By Distribution Channel
        • 11.3.2.2.5. By Application
        • 11.3.2.2.6. By End-User
    • 11.3.3. UAE Losartan Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Source
        • 11.3.3.2.2. By Form
        • 11.3.3.2.3. By Strength
        • 11.3.3.2.4. By Distribution Channel
        • 11.3.3.2.5. By Application
        • 11.3.3.2.6. By End-User
    • 11.3.4. Turkey Losartan Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Source
        • 11.3.4.2.2. By Form
        • 11.3.4.2.3. By Strength
        • 11.3.4.2.4. By Distribution Channel
        • 11.3.4.2.5. By Application
        • 11.3.4.2.6. By End-User
    • 11.3.5. Nigeria Losartan Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Source
        • 11.3.5.2.2. By Form
        • 11.3.5.2.3. By Strength
        • 11.3.5.2.4. By Distribution Channel
        • 11.3.5.2.5. By Application
        • 11.3.5.2.6. By End-User
    • 11.3.6. Kenya Losartan Market Outlook
      • 11.3.6.1. Market Size & Forecast
        • 11.3.6.1.1. By Value
      • 11.3.6.2. Market Share & Forecast
        • 11.3.6.2.1. By Source
        • 11.3.6.2.2. By Form
        • 11.3.6.2.3. By Strength
        • 11.3.6.2.4. By Distribution Channel
        • 11.3.6.2.5. By Application
        • 11.3.6.2.6. By End-User
    • 11.3.7. Algeria Losartan Market Outlook
      • 11.3.7.1. Market Size & Forecast
        • 11.3.7.1.1. By Value
      • 11.3.7.2. Market Share & Forecast
        • 11.3.7.2.1. By Source
        • 11.3.7.2.2. By Form
        • 11.3.7.2.3. By Strength
        • 11.3.7.2.4. By Distribution Channel
        • 11.3.7.2.5. By Application
        • 11.3.7.2.6. By End-User
    • 11.3.8. Ethiopia Losartan Market Outlook
      • 11.3.8.1. Market Size & Forecast
        • 11.3.8.1.1. By Value
      • 11.3.8.2. Market Share & Forecast
        • 11.3.8.2.1. By Source
        • 11.3.8.2.2. By Form
        • 11.3.8.2.3. By Strength
        • 11.3.8.2.4. By Distribution Channel
        • 11.3.8.2.5. By Application
        • 11.3.8.2.6. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Merck & Co. Inc.
  • 14.2. Pfizer Inc.
  • 14.3. Teva Pharmaceutical Industries Ltd.
  • 14.4. Sanofi S.A.
  • 14.5. Novartis International AG
  • 14.6. Dr. Reddy's Laboratories Ltd.
  • 14.7. Sun Pharmaceuticals Industries Ltd.
  • 14.8. Aurobindo Pharma Ltd.
  • 14.9. Torrent Pharmaceutical Ltd.
  • 14.10. Lupin Ltd.
  • 14.11. Mylan N.V.
  • 14.12. Ipca Laboratories Limited
  • 14.13. Macleods Pharmaceuticals Limited
  • 14.14. Abbott Laboratories
  • 14.15. Cadila Healthcare Limited

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Losartan Market Size, By Volume (USD Billion), 2016-2026F
  • Figure 3: Global Losartan Market Size, By Source (USD Billion), 2016-2026F
  • Figure 4: Global Losartan Market Share, By Form (USD Billion), 2016-2026F
  • Figure 5: Global Losartan Market Share, By Strength (USD Billion), 2016-2026F
  • Figure 6: Global Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
  • Figure 7: Global Losartan Market Share, By Application (USD Billion), 2016-2026F
  • Figure 8: Global Losartan Market Share, By End-User (USD Billion), 2016-2026F
  • Figure 9: Global Losartan Market Share, By Region (USD Billion), 2016-2026F
  • Figure 10: Global Losartan Market Share, By Company (USD Billion), 2016-2026F
  • Figure 11: Global Losartan Market Attractiveness Index, By Region, By Value, 2016-2026F
  • Figure 12: Global Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
  • Figure 13: North America Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 14: North America Losartan Market Size, By Source (USD Billion), 2016-2026F
  • Figure 15: North America Losartan Market Share, By Form (USD Billion), 2016-2026F
  • Figure 16: North America Losartan Market Share, By Strength (USD Billion), 2016-2026F
  • Figure 17: North America Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
  • Figure 18: North America Losartan Market Share, By Application (USD Billion), 2016-2026F
  • Figure 19: North America Losartan Market Share, By End-User (USD Billion), 2016-2026F
  • Figure 20: North America Losartan Market Share, By Country (USD Billion), 2016-2026F
  • Figure 21: North America Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 22: North America Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
  • Figure 23: United States Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 24: United States Losartan Market Size, By Source, 2016-2026F
  • Figure 25: United States Losartan Market Size, By Form, 2016-2026F
  • Figure 26: United States Losartan Market Size, By Strength, 2016-2026F
  • Figure 27: United States Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 28: United States Losartan Market Share, By Application, 2016-2026F
  • Figure 29: United States Losartan Market Share, By End-User, 2016-2026F
  • Figure 30: Canada Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 31: Canada Losartan Market Size, By Source, 2016-2026F
  • Figure 32: Canada Losartan Market Size, By Form, 2016-2026F
  • Figure 33: Canada Losartan Market Size, By Strength, 2016-2026F
  • Figure 34: Canada Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 35: Canada Losartan Market Share, By Application, 2016-2026F
  • Figure 36: Canada Losartan Market Share, By End-User, 2016-2026F
  • Figure 37: Mexico Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 38: Mexico Losartan Market Size, By Source, 2016-2026F
  • Figure 39: Mexico Losartan Market Size, By Form, 2016-2026F
  • Figure 40: Mexico Losartan Market Size, By Strength, 2016-2026F
  • Figure 41: Mexico Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 42: Mexico Losartan Market Share, By Application, 2016-2026F
  • Figure 43: Mexico Losartan Market Share, By End-User, 2016-2026F
  • Figure 44: Europe Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 45: Europe Losartan Market Size, By Source (USD Billion), 2016-2026F
  • Figure 46: Europe Losartan Market Share, By Form (USD Billion), 2016-2026F
  • Figure 47: Europe Losartan Market Share, By Strength (USD Billion), 2016-2026F
  • Figure 48: Europe Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
  • Figure 49: Europe Losartan Market Share, By Application (USD Billion), 2016-2026F
  • Figure 50: Europe Losartan Market Share, By End-User (USD Billion), 2016-2026F
  • Figure 51: Europe Losartan Market Share, By Country (USD Billion), 2016-2026F
  • Figure 52: Europe Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 53: Europe Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
  • Figure 54: Germany Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 55: Germany Losartan Market Size, By Source, 2016-2026F
  • Figure 56: Germany Losartan Market Size, By Form, 2016-2026F
  • Figure 57: Germany Losartan Market Size, By Strength, 2016-2026F
  • Figure 58: Germany Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 59: Germany Losartan Market Share, By Application, 2016-2026F
  • Figure 60: Germany Losartan Market Share, By End-User, 2016-2026F
  • Figure 61: France Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 62: France Losartan Market Size, By Source, 2016-2026F
  • Figure 63: France Losartan Market Size, By Form, 2016-2026F
  • Figure 64: France Losartan Market Size, By Strength, 2016-2026F
  • Figure 65: France Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 66: France Losartan Market Share, By Application, 2016-2026F
  • Figure 67: France Losartan Market Share, By End-User, 2016-2026F
  • Figure 68: United Kingdom Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 69: United Kingdom Losartan Market Size, By Source, 2016-2026F
  • Figure 70: United Kingdom Losartan Market Size, By Form, 2016-2026F
  • Figure 71: United Kingdom Losartan Market Size, By Strength, 2016-2026F
  • Figure 72: United Kingdom Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 73: United Kingdom Losartan Market Share, By Application, 2016-2026F
  • Figure 74: United Kingdom Losartan Market Share, By End-User, 2016-2026F
  • Figure 75: Italy Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 76: Italy Losartan Market Size, By Source, 2016-2026F
  • Figure 77: Italy Losartan Market Size, By Form, 2016-2026F
  • Figure 78: Italy Losartan Market Size, By Strength, 2016-2026F
  • Figure 79: Italy Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 80: Italy Losartan Market Share, By Application, 2016-2026F
  • Figure 81: Italy Losartan Market Share, By End-User, 2016-2026F
  • Figure 82: Spain Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 83: Spain Losartan Market Size, By Source, 2016-2026F
  • Figure 84: Spain Losartan Market Size, By Form, 2016-2026F
  • Figure 85: Spain Losartan Market Size, By Strength, 2016-2026F
  • Figure 86: Spain Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 87: Spain Losartan Market Share, By Application, 2016-2026F
  • Figure 88: Spain Losartan Market Share, By End-User, 2016-2026F
  • Figure 89: Russia Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 90: Russia Losartan Market Size, By Source, 2016-2026F
  • Figure 91: Russia Losartan Market Size, By Form, 2016-2026F
  • Figure 92: Russia Losartan Market Size, By Strength, 2016-2026F
  • Figure 93: Russia Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 94: Russia Losartan Market Share, By Application, 2016-2026F
  • Figure 95: Russia Losartan Market Share, By End-User, 2016-2026F
  • Figure 96: Poland Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 97: Poland Losartan Market Size, By Source, 2016-2026F
  • Figure 98: Poland Losartan Market Size, By Form, 2016-2026F
  • Figure 99: Poland Losartan Market Size, By Strength, 2016-2026F
  • Figure 100: Poland Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 101: Poland Losartan Market Share, By Application, 2016-2026F
  • Figure 102: Poland Losartan Market Share, By End-User, 2016-2026F
  • Figure 103: Asia-Pacific Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 104: Asia-Pacific Losartan Market Size, By Source (USD Billion), 2016-2026F
  • Figure 105: Asia-Pacific Losartan Market Share, By Form (USD Billion), 2016-2026F
  • Figure 106: Asia-Pacific Losartan Market Share, By Strength (USD Billion), 2016-2026F
  • Figure 107: Asia-Pacific Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
  • Figure 108: Asia-Pacific Losartan Market Share, By Application (USD Billion), 2016-2026F
  • Figure 109: Asia-Pacific Losartan Market Share, By End-User (USD Billion), 2016-2026F
  • Figure 110: Asia-Pacific Losartan Market Share, By Country (USD Billion), 2016-2026F
  • Figure 111: Asia-Pacific Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 112: Asia-Pacific Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
  • Figure 113: China Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 114: China Losartan Market Size, By Source, 2016-2026F
  • Figure 115: China Losartan Market Size, By Form, 2016-2026F
  • Figure 116: China Losartan Market Size, By Strength, 2016-2026F
  • Figure 117: China Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 118: China Losartan Market Share, By Application, 2016-2026F
  • Figure 119: China Losartan Market Share, By End-User, 2016-2026F
  • Figure 120: Japan Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 121: Japan Losartan Market Size, By Source, 2016-2026F
  • Figure 122: Japan Losartan Market Size, By Form, 2016-2026F
  • Figure 123: Japan Losartan Market Size, By Strength, 2016-2026F
  • Figure 124: Japan Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 125: Japan Losartan Market Share, By Application, 2016-2026F
  • Figure 126: Japan Losartan Market Share, By End-User, 2016-2026F
  • Figure 127: India Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 128: India Losartan Market Size, By Source, 2016-2026F
  • Figure 129: India Losartan Market Size, By Form, 2016-2026F
  • Figure 130: India Losartan Market Size, By Strength, 2016-2026F
  • Figure 131: India Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 132: India Losartan Market Share, By Application, 2016-2026F
  • Figure 133: India Losartan Market Share, By End-User, 2016-2026F
  • Figure 134: Australia Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 135: Australia Losartan Market Size, By Source, 2016-2026F
  • Figure 136: Australia Losartan Market Size, By Form, 2016-2026F
  • Figure 137: Australia Losartan Market Size, By Strength, 2016-2026F
  • Figure 138: Australia Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 139: Australia Losartan Market Share, By Application, 2016-2026F
  • Figure 140: Australia Losartan Market Share, By End-User, 2016-2026F
  • Figure 141: South Korea Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 142: South Korea Losartan Market Size, By Source, 2016-2026F
  • Figure 143: South Korea Losartan Market Size, By Form, 2016-2026F
  • Figure 144: South Korea Losartan Market Size, By Strength, 2016-2026F
  • Figure 145: South Korea Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 146: South Korea Losartan Market Share, By Application, 2016-2026F
  • Figure 147: South Korea Losartan Market Share, By End-User, 2016-2026F
  • Figure 148: Hong Kong Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 149: Hong Kong Losartan Market Size, By Source, 2016-2026F
  • Figure 150: Hong Kong Losartan Market Size, By Form, 2016-2026F
  • Figure 151: Hong Kong Losartan Market Size, By Strength, 2016-2026F
  • Figure 152: Hong Kong Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 153: Hong Kong Losartan Market Share, By Application, 2016-2026F
  • Figure 154: Hong Kong Losartan Market Share, By End-User, 2016-2026F
  • Figure 155: Philippines Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 156: Philippines Losartan Market Size, By Source, 2016-2026F
  • Figure 157: Philippines Losartan Market Size, By Form, 2016-2026F
  • Figure 158: Philippines Losartan Market Size, By Strength, 2016-2026F
  • Figure 159: Philippines Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 160: Philippines Losartan Market Share, By Application, 2016-2026F
  • Figure 161: Philippines Losartan Market Share, By End-User, 2016-2026F
  • Figure 162: Malaysia Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 163: Malaysia Losartan Market Size, By Source, 2016-2026F
  • Figure 164: Malaysia Losartan Market Size, By Form, 2016-2026F
  • Figure 165: Malaysia Losartan Market Size, By Strength, 2016-2026F
  • Figure 166: Malaysia Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 167: Malaysia Losartan Market Share, By Application, 2016-2026F
  • Figure 168: Malaysia Losartan Market Share, By End-User, 2016-2026F
  • Figure 169: Indonesia Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 170: Indonesia Losartan Market Size, By Source, 2016-2026F
  • Figure 171: Indonesia Losartan Market Size, By Form, 2016-2026F
  • Figure 172: Indonesia Losartan Market Size, By Strength, 2016-2026F
  • Figure 173: Indonesia Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 174: Indonesia Losartan Market Share, By Application, 2016-2026F
  • Figure 175: Indonesia Losartan Market Share, By End-User, 2016-2026F
  • Figure 176: Vietnam Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 177: Vietnam Losartan Market Size, By Source, 2016-2026F
  • Figure 178: Vietnam Losartan Market Size, By Form, 2016-2026F
  • Figure 179: Vietnam Losartan Market Size, By Strength, 2016-2026F
  • Figure 180: Vietnam Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 181: Vietnam Losartan Market Share, By Application, 2016-2026F
  • Figure 182: Vietnam Losartan Market Share, By End-User, 2016-2026F
  • Figure 183: Thailand Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 184: Thailand Losartan Market Size, By Source, 2016-2026F
  • Figure 185: Thailand Losartan Market Size, By Form, 2016-2026F
  • Figure 186: Thailand Losartan Market Size, By Strength, 2016-2026F
  • Figure 187: Thailand Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 188: Thailand Losartan Market Share, By Application, 2016-2026F
  • Figure 189: Thailand Losartan Market Share, By End-User, 2016-2026F
  • Figure 190: South America Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 191: South America Losartan Market Size, By Source (USD Billion), 2016-2026F
  • Figure 192: South America Losartan Market Share, By Form (USD Billion), 2016-2026F
  • Figure 193: South America Losartan Market Share, By Strength (USD Billion), 2016-2026F
  • Figure 194: South America Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
  • Figure 195: South America Losartan Market Share, By Application (USD Billion), 2016-2026F
  • Figure 196: South America Losartan Market Share, By End-User (USD Billion), 2016-2026F
  • Figure 197: South America Losartan Market Share, By Country (USD Billion), 2016-2026F
  • Figure 198: South America Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 199: South America Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
  • Figure 200: Brazil Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 201: Brazil Losartan Market Size, By Source, 2016-2026F
  • Figure 202: Brazil Losartan Market Size, By Form, 2016-2026F
  • Figure 203: Brazil Losartan Market Size, By Strength, 2016-2026F
  • Figure 204: Brazil Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 205: Brazil Losartan Market Share, By Application, 2016-2026F
  • Figure 206: Brazil Losartan Market Share, By End-User, 2016-2026F
  • Figure 207: Argentina Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 208: Argentina Losartan Market Size, By Source, 2016-2026F
  • Figure 209: Argentina Losartan Market Size, By Form, 2016-2026F
  • Figure 210: Argentina Losartan Market Size, By Strength, 2016-2026F
  • Figure 211: Argentina Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 212: Argentina Losartan Market Share, By Application, 2016-2026F
  • Figure 213: Argentina Losartan Market Share, By End-User, 2016-2026F
  • Figure 214: Colombia Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 215: Colombia Losartan Market Size, By Source, 2016-2026F
  • Figure 216: Colombia Losartan Market Size, By Form, 2016-2026F
  • Figure 217: Colombia Losartan Market Size, By Strength, 2016-2026F
  • Figure 218: Colombia Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 219: Colombia Losartan Market Share, By Application, 2016-2026F
  • Figure 220: Colombia Losartan Market Share, By End-User, 2016-2026F
  • Figure 221: Chile Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 222: Chile Losartan Market Size, By Source, 2016-2026F
  • Figure 223: Chile Losartan Market Size, By Form, 2016-2026F
  • Figure 224: Chile Losartan Market Size, By Strength, 2016-2026F
  • Figure 225: Chile Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 226: Chile Losartan Market Share, By Application, 2016-2026F
  • Figure 227: Chile Losartan Market Share, By End-User, 2016-2026F
  • Figure 228: Middle East and Africa Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 229: Middle East and Africa Losartan Market Size, By Source (USD Billion), 2016-2026F
  • Figure 230: Middle East and Africa Losartan Market Share, By Form (USD Billion), 2016-2026F
  • Figure 231: Middle East and Africa Losartan Market Share, By Strength (USD Billion), 2016-2026F
  • Figure 232: Middle East and Africa Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
  • Figure 233: Middle East and Africa Losartan Market Share, By Application (USD Billion), 2016-2026F
  • Figure 234: Middle East and Africa Losartan Market Share, By End-User (USD Billion), 2016-2026F
  • Figure 235: Middle East and Africa Losartan Market Share, By Country (USD Billion), 2016-2026F
  • Figure 236: Middle East and Africa Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
  • Figure 237: Middle East and Africa Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
  • Figure 238: South Africa Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 239: South Africa Losartan Market Size, By Source, 2016-2026F
  • Figure 240: South Africa Losartan Market Size, By Form, 2016-2026F
  • Figure 241: South Africa Losartan Market Size, By Strength, 2016-2026F
  • Figure 242: South Africa Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 243: South Africa Losartan Market Share, By Application, 2016-2026F
  • Figure 244: South Africa Losartan Market Share, By End-User, 2016-2026F
  • Figure 245: Saudi Arabia Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 246: Saudi Arabia Losartan Market Size, By Source, 2016-2026F
  • Figure 247: Saudi Arabia Losartan Market Size, By Form, 2016-2026F
  • Figure 248: Saudi Arabia Losartan Market Size, By Strength, 2016-2026F
  • Figure 249: Saudi Arabia Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 250: Saudi Arabia Losartan Market Share, By Application, 2016-2026F
  • Figure 251: Saudi Arabia Losartan Market Share, By End-User, 2016-2026F
  • Figure 252: UAE Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 253: UAE Losartan Market Size, By Source, 2016-2026F
  • Figure 254: UAE Losartan Market Size, By Form, 2016-2026F
  • Figure 255: UAE Losartan Market Size, By Strength, 2016-2026F
  • Figure 256: UAE Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 257: UAE Losartan Market Share, By Application, 2016-2026F
  • Figure 258: UAE Losartan Market Share, By End-User, 2016-2026F
  • Figure 259: Turkey Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 260: Turkey Losartan Market Size, By Source, 2016-2026F
  • Figure 261: Turkey Losartan Market Size, By Form, 2016-2026F
  • Figure 262: Turkey Losartan Market Size, By Strength, 2016-2026F
  • Figure 263: Turkey Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 264: Turkey Losartan Market Share, By Application, 2016-2026F
  • Figure 265: Turkey Losartan Market Share, By End-User, 2016-2026F
  • Figure 266: Nigeria Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 267: Nigeria Losartan Market Size, By Source, 2016-2026F
  • Figure 268: Nigeria Losartan Market Size, By Form, 2016-2026F
  • Figure 269: Nigeria Losartan Market Size, By Strength, 2016-2026F
  • Figure 270: Nigeria Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 271: Nigeria Losartan Market Share, By Application, 2016-2026F
  • Figure 272: Nigeria Losartan Market Share, By End-User, 2016-2026F
  • Figure 273: Kenya Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 274: Kenya Losartan Market Size, By Source, 2016-2026F
  • Figure 275: Kenya Losartan Market Size, By Form, 2016-2026F
  • Figure 276: Kenya Losartan Market Size, By Strength, 2016-2026F
  • Figure 277: Kenya Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 278: Kenya Losartan Market Share, By Application, 2016-2026F
  • Figure 279: Kenya Losartan Market Share, By End-User, 2016-2026F
  • Figure 280: Algeria Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 281: Algeria Losartan Market Size, By Source, 2016-2026F
  • Figure 282: Algeria Losartan Market Size, By Form, 2016-2026F
  • Figure 283: Algeria Losartan Market Size, By Strength, 2016-2026F
  • Figure 284: Algeria Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 285: Algeria Losartan Market Share, By Application, 2016-2026F
  • Figure 286: Algeria Losartan Market Share, By End-User, 2016-2026F
  • Figure 287: Ethiopia Losartan Market Size, By Value (USD Billion), 2016-2026F
  • Figure 288: Ethiopia Losartan Market Size, By Source, 2016-2026F
  • Figure 289: Ethiopia Losartan Market Size, By Form, 2016-2026F
  • Figure 290: Ethiopia Losartan Market Size, By Strength, 2016-2026F
  • Figure 291: Ethiopia Losartan Market Size, By Distribution Channel, 2016-2026F
  • Figure 292: Ethiopia Losartan Market Share, By Application, 2016-2026F
  • Figure 293: Ethiopia Losartan Market Share, By End-User, 2016-2026F